Ewing Sarcoma Clinical Trials

114 clinical trials for Ewing Sarcoma across international registries, including 41 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) — RECRUITING · PHASE1
• Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas — RECRUITING · PHASE1
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) — RECRUITING · PHASE1
• Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma — RECRUITING
• Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) — RECRUITING · PHASE1
• Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma — RECRUITING · NA
• Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma — RECRUITING · PHASE2
• International open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma — RECRUITING · PHASE1
• A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors — RECRUITING · PHASE1
• Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors — RECRUITING · PHASE1
• Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors — RECRUITING · PHASE1
• Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas — RECRUITING · PHASE1
• Combination Immunotherapy Targeting Sarcomas — RECRUITING · PHASE1
• XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma — RECRUITING · PHASE2
• Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial — RECRUITING · NA
• A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies — RECRUITING · PHASE1
• Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas — RECRUITING · PHASE1
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision) — RECRUITING · PHASE1
• Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies — RECRUITING · PHASE1
• Lurbinectedin in FET-Fused Tumors — RECRUITING · PHASE1
• Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas — RECRUITING · NA
• Hypofractionated Radiation in Combination With B7-H3-CAR T Cells for Pediatric Patients With Relapsed/Refractory Sarcomas — RECRUITING · PHASE1
• Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma — RECRUITING · PHASE1
• Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery — RECRUITING
• HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma — RECRUITING · PHASE1
• Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas — RECRUITING · PHASE1
• Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors — RECRUITING · PHASE1
• Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas — RECRUITING · PHASE2
• Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method — RECRUITING
• Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma — RECRUITING · PHASE2
• Early Ageing During Therapy in AYA Cancer Patients — RECRUITING
• To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly) — RECRUITING · PHASE2
• Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma — RECRUITING
• A Prospective, Randomized, Controlled Clinical Study on the Prevention of Chemotherapy Related Myelosuppression in Patients with Ewing's Sarcoma Using Trilaciclib — RECRUITING · PHASE2
• Analysis of the Toxicity and Efficacy of Daily 1 vs 2 Beam Proton Therapy — RECRUITING · NA
• A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma — RECRUITING · PHASE2
• Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma — RECRUITING · PHASE1
• Use of GnRHa During Chemotherapy for Fertility Protection — RECRUITING · PHASE3
• Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse — RECRUITING · PHASE2
• Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• INTER-EWING-1: International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma – Trial 1 — TERMINATED · PHASE3
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• EWSR1 Immunotherapy in Ewing Sarcoma and DSRCT — NOT_YET_RECRUITING · PHASE1
• Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma — NOT_YET_RECRUITING · NA
• Methionine PET/CT Studies In Patients With Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Neoadjuvant Radiotherapy and Surgery for High-Risk Localized Ewing Sarcoma — NOT_YET_RECRUITING
• Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD — ACTIVE_NOT_RECRUITING · NA
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search